Tag: dispensaries
-
Cannabis Life Sciences (CSE:CLSH.U): The US multi state operator value pick
I love it when the market is busy fighting over inflated market caps, because I’m a Moneyball guy. I like value, and while a lot of money has moved toward Canadian cannabis operators in recent years, the size of the market down south is only now starting to become clear. There’s still some value floating…
-
iAnthus (IAN.C) in pole position as New Jersey green-lights legal rec weed
On March 12, 2019 New Jersey legislators joined Democratic Governor Phil Murphy to announce a bill legalising adult-use marijuana in the Garden State. Murphy spent 23 years clawing his way up the corporate ladder at Goldman Sachs (GS.NYSE), eventually becoming global co-head of the $370 billion Investment Management Division. The legislation permits municipalities to collect…
-
Westleaf (WL.V) brings prairie focus, first nations connections, novel ideas
I first heard about the Prairie Records cannabis retail business model mid last year. And my first thought upon seeing it was, this will never be allowed. Basically, instead of keeping everything behind glass and having consumers guess as to what weed they’re looking at and what it will do, Westleaf’s retail model is to…
-
Dispensing dispensary wisdom: Solo Growth (SOLO.V) plays the long game
In early 2018, Aurora Cannabis (ACB.T) made one of their most interesting asset acquisitions to date, when it bought into the Liquor Stores N.A. chain, snaring 19.9% for $103.5 million. It was the sort of balls out deal Aurora is famous – or infamous, depending on your viewpoint – for, bursting out into a new…
-
Gamechanger: iAnthus (IAN.C) and MPX Bioceutical (MPX.C) to merge, go after MedMen (MMEN.C)
A week ago, US dispensary roll-up play MedMen (MMEN.C) closed an $86m financing and a $99.95m loan to help them complete a $682m deal to buy PharmaCann, which has ten dispensaries and three weed grows. It was big news and propelled MMEN stock, which many deem to be overpriced before the deal, substantially higher still.…
-
MedMen (MMEN.C) blows out stock to buy 10 dispensaries, three weed farms in Pharmacann deal
In news that pushed MedMen’s (MMEN.C) share price to new highs, the red shirt crew have announced they’re buying US based Pharmacann LLC for $682 million… or, rather, $682 million of MMEN stock, as of October 9. Mind you, the news drove the company share price up significantly, meaning the actual price now being paid…
-
MedMen (MMEN.C) legal demands clearer: Half a billion dollars from EquityGuhahahahaha
The Streisand Effect is what happens when a person or company sends out legal threats to stop people from seeing something and, in turn, makes that thing they didn’t want seen go viral. MedMen’s lawyers probably should have talked to their clients about this before they started sending us weird legal demands because wow, you…
-
C21 Investments (CXXI.C) makes big $25m+ acquisition of Nevada grower, dispensary pioneer
The market is enjoying news released by C21 Investments (CXXI.C) that it has agreed to acquire Silver State Relief LLC and Silver State Cultivation LLC, for a sum that dwarfs any previous Canada-buys-US-assets deal, and adds nicely to its growing portfolio of US cannabis assets. President and CEO of C21 Robert Cheney stated: “Our entire C21…
-
Green Organic Dutchman (TGOD.T) & MedMen (MMEN.C) have big days, but only one is smiling
The Green Organic Dutchman (TGOD.T) is nearing being a billion dollar company, after its stock ran up 13.9% today on news that it would license soluble cannabinoid tech from Stillwater Foods. The Green Organic Dutchman Holdings Ltd. has entered into an exclusive agreement with Stillwater Brands to license Ripple SC (soluble cannabinoids) ingredient technology, and…